Evidence map›Paper›PMID 37489514›Full record

ArticleEpidemiology and infection2023

COVID-19 second wave and clinical characteristics of cases in Uganda: A retrospective cross-sectional survey of confirmed SARS-CoV-2 cases, March-June 2021.

Abel Wilson Walekhwa, Brenda Nakazibwe, Mary Nantongo, Solomon Tsebeni Wafula, Douglas Bulafu, Brenda Ayugi, Caroline Nankabirwa, Godfrey Nsereko, Martha Dorcas Nalweyiso, Tonny Tindyebwa and 5 more

Abstract readCase Reports
In one paragraph

Article in Epidemiology and infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Abel Wilson WalekhwaScience, Technology and Innovation Secretariat- Office of the President, Kampala, Uganda.ORCID 0000-0001-9690-4650
Brenda NakazibweScience, Technology and Innovation Secretariat- Office of the President, Kampala, Uganda.
Mary NantongoScience, Technology and Innovation Secretariat- Office of the President, Kampala, Uganda.
Solomon Tsebeni WafulaMakerere University School of Public Health, Kampala, Uganda.
Douglas BulafuMakerere University School of Public Health, Kampala, Uganda.
Brenda AyugiMakerere University School of Public Health, Kampala, Uganda.
Caroline NankabirwaMakerere University College of Veterinary Medicine, Animal Resources and Biosecurity, Kampala, Uganda.
Godfrey NserekoMinistry of Health, Kampala, Uganda.
Martha Dorcas NalweyisoMakerere University College of Veterinary Medicine, Animal Resources and Biosecurity, Kampala, Uganda.
Tonny TindyebwaMakerere University School of Public Health, Kampala, Uganda.
Roy William MayegaMakerere University School of Public Health, Kampala, Uganda.
Abel Bulamu EkiriSchool of Veterinary Medicine, University of Surrey, UK.
Danstan BagendaUniversity of Nebraska Medical Center, Omaha, NE, USA.
Monica MuseneroScience, Technology and Innovation Secretariat- Office of the President, Kampala, Uganda.
Lawrence MugishaScience, Technology and Innovation Secretariat- Office of the President, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted a retrospective cross-sectional population-based survey among recovered COVID-19 cases in Uganda to establish the case presentations of the second wave SARS-CoV-2 infections. We interviewed 1,120 recovered COVID-19 cases from 10 selected districts in Uganda. We further conducted 38 key informant interviews with members of the COVID-19 District Taskforce and 19 in-depth interviews among COVID-19 survivors from March to June 2021. Among them, 62% were aged 39 years and below and 51.5% were female with 90.9% under home-based care management. Cases were more prevalent among businesspeople (25.9%), students (16.2%), farmers (16.1%), and health workers (12.4%). Being asymptomatic was found to be associated with not seeking healthcare (APR 2, P < 0.001). The mortality rate was 3.6% mostly among the elderly (6.3%) and 31.3% aged 40 years and above had comorbidities of high blood pressure, diabetes, and asthma. Being asymptomatic, or under home-based care management (HBCM), working/operating/studying at schools, and not being vaccinated were among the major drivers of the second wave of the resurgence of COVID19 in Uganda. Managing future COVID-19 waves calls for proactive efforts for improving homebased care services, ensuring strict observation of SOPs in schools, and increasing the uptake of COVID-19 vaccination.

Indexed as

COVID-19SARS-CoV-2AgedCOVID-19 VaccinesCross-Sectional StudiesFemaleHumansMaleRetrospective StudiesUgandaCOVID-19 Vaccinesasymptomatic patientscharacteristicsCOVID-19second waveUganda

Identifiers

PMID37489514
PMCPMC10894928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.